BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9145628)

  • 1. Factors associated with elective Norplant removal in black and white women.
    Opara JU; Ernst FA; Gaskin H; Smith L; Nevels HV
    J Natl Med Assoc; 1997 Apr; 89(4):237-40. PubMed ID: 9145628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the acceptability of Norplant contraceptive in four patient populations.
    Dugoff L; Jones OW; Allen-Davis J; Hurst BS; Schlaff WD
    Contraception; 1995 Jul; 52(1):45-9. PubMed ID: 8521714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and experiences of American women electing for early removal of contraceptive implants.
    Frank ML; Ditmore JR; Ilegbodu AE; Bateman L; Poindexter AN
    Contraception; 1995 Sep; 52(3):159-65. PubMed ID: 7587187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levonorgestrel implant use among adolescents.
    Mashburn M
    J Pediatr Health Care; 1994; 8(6):255-60. PubMed ID: 7799199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary experience with Norplant in an inner city population.
    Cullins VE; Blumenthal PD; Remsburg RE; Huggins GR
    Contraception; 1993 Feb; 47(2):193-203. PubMed ID: 8449019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Norplant implants among Thai women in Bangkok.
    Chompootaweep S; Kochagarn E; Sirisumpan S; Tang-usaha J; Theppitaksak B; Dusitsin N
    Contraception; 1996 Jan; 53(1):33-6. PubMed ID: 8631187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescents and Norplant: preliminary findings of side effects.
    Kozlowski KJ; Rickert VI; Hendon A; Davis P
    J Adolesc Health; 1995 May; 16(5):373-8. PubMed ID: 7662687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient satisfaction with a levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal.
    Haugen MM; Evans CB; Kim MH
    J Reprod Med; 1996 Nov; 41(11):849-54. PubMed ID: 8951137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with side effects and health risks associated with Norplant implant use in adolescents.
    Rosenthal SL; Biro FM; Kollar LM; Hillard PJ; Rauh JL
    Contraception; 1995 Nov; 52(5):283-5. PubMed ID: 8585884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Education and counseling for Norplant users.
    Hinkle LT
    J Obstet Gynecol Neonatal Nurs; 1994 Jun; 23(5):387-91. PubMed ID: 8083779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menstrual bleeding patterns in Norplant-2 implant users.
    Biswas A; Leong WP; Ratnam SS; Viegas OA
    Contraception; 1996 Aug; 54(2):91-5. PubMed ID: 8842585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
    Sivin I; Campodonico I; Kiriwat O; Holma P; Diaz S; Wan L; Biswas A; Viegas O; el din Abdalla K; Anant MP; Pavez M; Stern J
    Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norplant implants in the UK: first year continuation and removals.
    Peers T; Stevens JE; Graham J; Davey A
    Contraception; 1996 Jun; 53(6):345-51. PubMed ID: 8773421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Norplant implants in a New York City clinic population.
    Gerber S; Westhoff C; Lopez M; Gordon L
    Contraception; 1994 Jun; 49(6):557-64. PubMed ID: 8070260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraceptive implant use among inner city teens.
    Glantz S; Schaff E; Campbell-Heider N; Glantz JC; Bartlett M
    J Adolesc Health; 1995 May; 16(5):389-95. PubMed ID: 7662690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subdermal contraceptive implants in nurse-midwifery practice.
    Emerling JM; Paluzzi P; Leiva J; Cullins VE
    J Nurse Midwifery; 1993; 38(2 Suppl):80S-87S. PubMed ID: 8483013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuation rates of long-acting methods of contraception. A comparative study of Norplant implants and intrauterine devices.
    Fleming D; Davie J; Glasier A
    Contraception; 1998 Jan; 57(1):19-21. PubMed ID: 9554246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subdermal contraceptive implants.
    Peralta O; Diaz S; Croxatto H
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):223-6. PubMed ID: 7626459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Return of fertility following discontinuation of Norplant-II subdermal implants. ICMR Task Force on Hormonal Contraception.
    Buckshee K; Chatterjee P; Dhall GI; Hazra MN; Kodkany BS; Lalitha K; Logambal A; Manchanda P; Nanda UK; RaiChoudhury G
    Contraception; 1995 Apr; 51(4):237-42. PubMed ID: 7796589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.